Skip to main content
Signal8
Launch Terminal
Shapiro Benjamin profile photo

Benjamin Shapiro

CIK: 0001974846

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ORAMED PHARMACEUTICALS INC. logo
ORMP

ORAMED PHARMACEUTICALS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Dec 31, 2025
    Award(A)
    Direct
    30K shares-
  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Dec 31, 2025
    Award(A)
    Direct
    3.5K shares-
  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Jun 5, 2025
    Award(A)
    Direct
    30K shares-
  • ORAMED PHARMACEUTICALS INC. logo
    ORMP

    ORAMED PHARMACEUTICALS INC.

    Jun 5, 2025
    Award(A)
    Direct
    4.7K shares-

1-4 of 4

About Shapiro Benjamin

Shapiro Benjamin (SEC CIK 0001974846) files insider reports with the SEC as Director of ORAMED PHARMACEUTICALS INC. (ORMP).

Signal8 holds 2 ownership filings by Shapiro Benjamin, all Form 4s, filed between Jun 9, 2025 and Jan 5, 2026. Those filings report 4 transactions, from Jun 5, 2025 to Dec 31, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Shapiro Benjamin's filings is in NEW YORK, NY.

Recent filings by Shapiro Benjamin

  • Dec 31, 2025: Grants or awards of ORMP shares (2 lines, Form 4, code A).
  • Jun 5, 2025: Grants or awards of ORMP shares (2 lines, Form 4, code A).

Other insiders filing for ORAMED PHARMACEUTICALS INC. (ORMP)

How to read Form 4 transaction codes